{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Updates in Nonalcoholic Fatty Liver Disease

Activity Steps


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the rising prevalence of non-alcohol fatty liver disease (NAFLD)/MASLD in practice.
  2. Explain how to manage patients with NAFLD/MASLD in clinical practice.
  3. Identify patient populations at risk for NAFLD and evaluate them according to guidelines.
Price: $30.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: CLD1123D
Published: November 2023
Expires: 10/31/2025
Required Passing Score: 2/3 (66%)
Authors: Manida Wungjiranirun, Nicole Wong, Janice Jou and Cynthia A. Moylan
Categories: Hepatology
Specialties: Hepatology